• Users Online: 145
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Referee Resource Subscribe


 
 Table of Contents  
REVIEW ARTICLE
Year : 2016  |  Volume : 3  |  Issue : 2  |  Page : 66-79

An outline on the aetiopathological association of genetic polymorphisms in women with female genital tuberculosis


Department of Zoology, UCS, Osmania University; Department of Biotechnology & Bioinformatics, SLS, University of Hyderabad, Hyderabad, Telangana, India

Date of Web Publication16-Nov-2017

Correspondence Address:
Venkanna Bhanothu
Room No. F70, Department of Biotechnology & Bioinformatics, SLS, University of Hyderabad, Hyderabad-500046, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/fsr.fsr_4_17

Rights and Permissions
  Abstract 

The aetiopathological association of genetic polymorphisms in women with female genital tuberculosis (FGTB) is not understood completely. This review summarises the role of gene polymorphisms in Mycobacterium tuberculosis infection leading to infertility and switching on of the toll-like receptor 2 (TLR2) as well as the interferon-gamma (IFN-γ) signalling mechanisms and attempts to give information on amplification refractory mutation system (ARMS)–multi-gene (MG)/multi-primer (MP) polymerase chain reaction (PCR). The study was conducted in the Department of Zoology, Osmania University, Hyderabad, India. Desired articles for systematic reviews and meta-analysis strategies were used for the critically review. Keywords and internet searches were conducted in all electronic databases from the beginning of September 03, 2006 to July 07, 2017. Full-text, English language reviews and research articles based on FGTB, gene polymorphism and infertility were included. This review provides a comprehensive overview on the role of genetic polymorphism and mycobacterium infection in causing infertility, related symptoms and highlights the role of ARMS–MG/MP PCR for the detection of gene polymorphisms among infertile patients with FGTB. A total of 163 studies were recognised; only a minimum number of reviews (n = 4/163, 2.45%) scored well. A review on the association of genetic polymorphism in a well-characterised set of infertile patients with FGTB and healthy control women without tuberculosis was chosen as main outcome. This study noted that more research is needed to correlate mutations in TLR2 and IFN-γ along with the functional consequences of other factors and recommends considering the ARMS–MG/MP PCR for a rapid analysis of any known mutation in genomic deoxyribonucleic acid.

Keywords: Amplification refractory mutation system–multi-gene/multi-primer polymerase chain reaction, female genital tuberculosis, gene polymorphism, toll-like receptor 2 and interferon-gamma-mediated positive feedback loop mechanism


How to cite this article:
Bhanothu V. An outline on the aetiopathological association of genetic polymorphisms in women with female genital tuberculosis. Fertil Sci Res 2016;3:66-79

How to cite this URL:
Bhanothu V. An outline on the aetiopathological association of genetic polymorphisms in women with female genital tuberculosis. Fertil Sci Res [serial online] 2016 [cited 2017 Dec 15];3:66-79. Available from: http://www.fertilityscienceresearch.org/text.asp?2016/3/2/66/218548




  Introduction Top


Female genital tuberculosis (FGTB) is a persistent infection usually having a low-grade symptomatology with very few exact complaints. It is the foremost reason of childlessness and is a multifaceted condition with a myriad of causes, diagnosis and treatment. The rate of female infertility is rising and varies from 10 to 20%.[1] The worldwide incidence of infertility in genital tuberculosis (GTB) varies from 10 to 87%;[2],[3] this condition is extremely prevalent in India,[4] with an incidence of 58%[5] and the majority of the patients are in the reproductive age (15–45 years) group.[6] The disease is predisposed for 5% of all female pelvic infections and arises in 15–20% cases of extra-pulmonary tuberculosis (EPTB).[7] In 80–90% cases, it involves women with menstrual abnormalities accounting for about 27% of the manifestations of FGTB.[8]

The pathogenicity and machinery of host reaction to FGTB is very divisive and still uncertain. The primary assault occurs with a few bacilli, which gradually inhabit and proliferate locally without causing symptoms. The primary infectivity of the genitalia may rarely arise from direct inoculation during sexual intercourse[9] with an infected cohort suffering from the tuberculous lesions of the genitalia.[10] The tuberculosis (TB) injuries are extremely dynamic and shaped by both, immune response elements and the pathogens. This co-evolutionary outlook emphasises the mutual shaping of the tissue microenvironment, which allows the breeding and transmission of Mycobacterium tuberculosis (M. tuberculosis) yet restricts tissue injure to safeguard the survival of the host. Once the genital tract is colonised, granulomata-containing viable tubercle bacilli form within various pelvic organs. After the development of tubercular hypersensitivity, these generally become clinically silent and intervals of 1–10 years or even longer may pass before infection at this site is reactivated or becomes clinically evident, if symptoms occur at all.[11] Once an active disease is established, then irreversible tubal and endometrial damage can occur and leads to the spread of granuloma to other organs. These are described as having compact, organised aggregates of immune cells consisting of blood-derived infected and uninfected macrophages, foamy macrophages, epithelioid cells (uniquely differentiated macrophages), and multinucleated giant cells (Langerhans cells) surrounded by a ring of lymphocytes. It generally remains silent, and physical signs are usually not present; hence, the disease remains mostly undiagnosed, or else, specific investigations are not commenced to rule out the problem. It is known that tuberculous foci may exist in the body and remain undetected for a long period.

The  Fallopian tube More Detailss are typically considered to be sterile; however, pathogenic microorganisms can come up from the lower tract (the cervix infection) and cause infection and inflammation in the upper female reproductive tract (FRT).[12] The stretch of the pathogen to the fallopian tubes, endometrial mucosa and ovaries leads to a variety of clinical conditions[11] such as infertility, irregular menstruation and pelvic pain. Clinical presentations such as oophoritis (inflammation of the ovaries) are also commonly seen in combination with salpingitis (inflammation of the fallopian tubes). During the pre-clinical stage, an insidious, low-grade inflammation is likely to modify the function of the fallopian tubes, uterus and endometrium, which leads to subtle damage and functional loss of the uterus and the tubes. The infection as it reaches the endometrium may persist in the basal layer, not shed during menstruation and/or infects the tubes following menstruation. In the cervix, the tuberculous lesion can be ulcerative or proliferative or may present as a mass mimicking malignancy.[13] The lesions in the cervix and vagina are usually present as isolated, chronic, ulcerative lesions.[14] In ulcerative form, the ulcers have serpiginous outline, clean-cut edges and a yellow base. Early ulcers are often seen near the opening of the central cervical canal into the vagina (i.e. external os). The signs, symptoms and the altered immune responses of patients with FGTB imitate those of immunosuppressed persons; therefore, diagnostic attentiveness may prevent unnecessary treatment and morbidity.[15]

Immune defence system of the reproductive tract

Although bacterial infections are predisposed by environmental factors, a range of strong host genetic factor heaviness is also likely during the interaction between humans and potential bacterial strains through the immune system and inflammatory signalling pathways, consequential in host immune responses and inflammation.[16] The host immune response against pathogen is orchestrated by the innate and cellular arms of the immune system along with antibody-mediated immunity. Furthermore, the innate immune system of the FRT is categorised in to mechanical, chemical and cellular components.[17] The anterior urethra and cervicovagina are the only anatomic areas of the genital tract system perpetually colonised with microbes and termed as the reproductive tract microbiome.[18] The mucus lining and epithelial cells along with protective microbiome act as the mechanical barriers. Besides being a physical barrier for microorganisms, the mucosal epithelial cells may actively contribute in the mucosal immune defence by secreting cytokines in response to pathogens.[19] The chemical barriers are natural anti-microbial peptides and pattern recognition receptors (PRRs)[20] that offer the first line of defence against the invading classes of pathogens and incorporate immune response quickly after dealing with infectious agents. As a consequence, the activation of adaptive immune system takes place by improving the surface defences, cytokine elaboration, cellular complement activation and phagocytic responses[21] as a part of host defence.[21],[22]

The innate immune system has the ability to recognise the structurally conserved distinct products of microbial metabolism present in a wide variety of microorganisms and mediates the immune responses. These conserved products, termed pathogen-associated molecular patterns (PAMPs),[23] are recognised by germline-encoded membrane-bound receptors expressed mainly on the host immune cells termed PRRs.[21],[24] A cascade of events occur following PAMPs recognition by PRRs, which activates host defence mechanism to prevent or fight off infections and subsequently initiate signalling and enhance adaptive immune response.[25]

Many functions of innate immunity are transduced through PRRs, which recognise invading microbes and activate signalling pathways that initiate immune and inflammatory responses to destroy the invaders or pathogens. Recent studies have consigned a critical role to one particular group of PRRs including the evolutionarily conserved mammalian toll-like receptor (TLR), a family of extremely similar proteins.[26] TLRs are a family of PRRs consisting of 13-member eukaryotic receptor forms, as of an ancient gene group, which is found in invertebrates and vertebrates.[21],[27] In humans, ten functional TLRs (TLRs 1–10) have been recognised.[28] TLRs 1–6 have constantly been reported in human and mouse reproductive tract epithelial cell lines (endocervical, ectocervical, vaginal and uterine cell lines) and endometrial epithelial cells.[29],[30],[31] The expressions of different TLRs in the FRT are summarised in [Table 1].[32],[33] The expressions of TLR1-10 genes are also reported in the human endometrium and endometrial tissue (excluding menstruation samples), and the mean relative expression of TLR2–6, 9 and 10 genes was reported to be significantly higher during the secretary phase when evaluated in comparison with other phases of the menstrual cycle.[31],[34]
Table 1: TLR expression in epithelial cells isolated from the different sites of the FRT

Click here to view


The pattern recognition of M. tuberculosis is a complex process initiated by bacterial contact with macrophages, in which, the multitude of receptor proteins identifies specific components of the microorganism.[35] The recognition of mycobacteria by specific receptors leads to the up-regulation of diverse intracellular signalling pathways, to integrate and induce an efficient signalling in the activation of the innate host defence mechanism and the subsequent overture of adaptive immune response. Among all the functional TLRs described in humans, the cytoplasmic domain of TLR2 is exceptional in its requirement, because it forms functional heterodimeric complexes with either TLR1 or TLR6 for the instigation of cellular signalling, cellular response, immune modulation and the immune regulation of reproductive functions. TLR2 does not form a homodimer by itself; thus, TLR2 is considered to be the most vital receptor in identifying a vast array of ligands, including a broad range of microbial products from gram-positive bacteria (peptidoglycan),[36] fungi (zymosan),[37] bacterial lipopeptide[38] including synthetic lipoproteins S- [2,3-Bis(palmitoyloxy)propyl]-N-palmitoylcysteinyl-seryl-lysyl-lysyl-lysyl-lysine (Pam3Cys-Ser-(Lys)4)[39] and eventually leading to a cascade of signalling responsible for cytokine induction [Table 2]. TLR2/TLR1 and TLR2/TLR6 heterodimeric forms have been implicated mostly in the detection of mycobacterial cell wall glycolipids, and lipopeptides/lipoproteins such as 38-kDa protein, LpqH (19-kDa lipoprotein, Rv3763),[40] lipoprotein signal peptidase (LspA), lipoprotein-LprA (Rv1270),[41] lipoprotein-LprG (Rv1411c),[42] triacylated lipoproteins or diacylated lipoproteins[43] consequently trigger cascade signals.[44] Other than the lipoproteins, TLR2 also interacts with lipopolysaccharides, lipoteichoic acid, lipoarabinomannan, lipomannan,[45] peptidoglycan and phosphatidylinositol mannoside[46] along with endogenous ligands (heat shock proteins) released by damaged or necrotic host cells[47] to initiate the cellular responses.[46] However, a recent study showed that only lipoproteins/lipopeptides were ‘true’ TLR2 ligands and accepted as ligands at physiological concentrations.[48] It was also measured that the differential immune responses were mediated by totally distinct chemical structures of mycobacterial components and the dimerisation, heterodimeric rearrangements and conformational transforms of TLR2 receptor in response to ligand interaction.[49]
Table 2: Toll-like receptor 2 specific microbial components[49]]

Click here to view


Toll-like receptor 2 and interferon-gamma genes polymorphism

TLR2, a protein that in humans is encoded by the TLR2 gene,[50] is also designated as cluster of differentiation factor (CD) 282. TLR2 is a very attractive receptor that plays a crucial role in pathogen recognition, essential for the initiation and coordination of the innate immune responses to distinguish the pathogens[49],[51] and enhance the adaptive immunity cascades of effector responses against pathogens.[52] Thus, TLR2 is known as the key sensor of mycobacterial infections. After infection with M. tuberculosis, primary host immune response cells, such as the dendritic cells (DC) and macrophages, engulf mycobacteria by phagocytosis and present pathogen-derived peptide antigens to naive T lymphocytes (mature in the thymus) (T-cells). Host innate immune cells sense the existence of mycobacterial-derived components through the activation of TLR2. Although the interaction of M. tuberculosis with TLRs leads to phagocyte activation, the communication itself does not lead to the immediate ingestion of the mycobacteria. Subsequent to the interaction of specific mycobacterial structures with TLRs, the outcome of signalling through TLR2 can be explained in part by the selective usage of five types of adaptor molecules namely myeloid differentiation primary response gene 88 (MyD88), toll/interleukin receptor-domain-containing adaptor protein (TIRAP)/MyD88-adaptor-like (MAL), TIR-domain-containing adaptor-inducing interferon (IFN)-β (TRIF)/TIR-domain-containing molecule 1 (TICAM1), TRIF-related adaptor molecule (TRAM) and sterile alpha- and armadillo motif-containing protein (SARM). Macrophages and DC sense the presence of mycobacteria through the activation of TLR2.

This results in the production of cellular mediators such as interleukin (IL)-1, IL-6 and IL-12 that in turn activate CD4+ and CD8+ T-cells. Activated T-cells produce IFN-γ and other mediators that result in the positive feedback loop (IL-12 → T-cell → IFN-γ) mechanism involved in the activation of macrophages to kill intracellular pathogens in later events, as are shown in [Figure 1].[53],[54],[55],[56],[57] Strong evidence is available for the selection of genetic variants in modulating infectivity and differential clinical presentation for genes encoding several types of proteins[16] including macrophage receptors, soluble C-type lectins, TLRs,[58] major histocompatibility complex/human leucocyte antigen,[59] cytokines and chemokines.[60] Among these, TLR2 and IFN-γ genes are most important, because TLR2 signalling pathway contributes to IFN-γ production.[61],[62],[63] TLR2 gene in particular plays an important role in pathogen recognition, initiating the signalling cascades and arbitrates the interactions between the immune and reproductive systems[64] in response to pathogen. Holland and Casanova described the role of IL-12 and IFN-γ in the stimulation of macrophages and T-cells in response to mycobacterial infections.[65] Upon infection, primary host response cells such as macrophages release a range of cytokines including IL-12, which stimulates T-cells or natural killer (NK) cells to produce IFN-γ. IFN-γ activates macrophages to destroy intracellular pathogens and enhance the differentiation of IFN-γ-producing T helper cells. The risk of developing TB has been shown to be associated with arginine 753 glutamine (R753Q) polymorphisms in the TLR2 gene,[66],[67] and more specifically with shorter guanine-thymine (GT) repeat polymorphism in intron II of the TLR2 gene. However, earlier studies have reported the lower expression of TLR2 protein[68] on their coexistence.
Figure 1: The toll-like receptor 2 and interferon-gamma-mediated positive feedback loop mechanism in response to M. tuberculosis: expression of immune response genes in the macrophages/dendritic cells leads to activation of natural killer cells/T cells for the production of IFN-γ, other mediators and elimination of bacilli.[37],[53],[54],[57]

Click here to view


TLR2 plays an important role in protecting the host from various pathogens including M. tuberculosis.[69] However, single nucleotide polymorphisms (SNPs) in the human TLR2 gene have been linked with a decreased response to various bacterial lipoproteins and septic shock following a gram-positive bacterial infection. TLR2 polymorphisms associated with TB signify the regulatory variants rather than non-synonymous SNPs that alter the amino acid sequence.[70] The patients heterozygous for arginine 753 glutamine (R753Q) had reduced production levels of IFN-γ signifying that altered TLR2 responsiveness might contribute to the course of infections[66],[69],[71],[72] including TB.[66],[67],[70],[73] In human, SNPs located in the first intron of the IFN-γ gene (at position +874) have shown variable associations with disease susceptibility and severity.[74] There are two well-known SNPs in the IFN-γ gene non-coding region (intron 1): +874A/T polymorphism and CA microsatellite. SNPs are single-allele mutations [deoxyribonucleic acid (DNA) sequence variations that occur when a single nucleotide [adenine (A), T, cytosine (C) or G] in the genome sequence is altered] in the genomic sequence of an organism, which are responsible for about 90% of all human DNA variation and play significant role in human evolution, drug sensitivity and disease susceptibility.[75] Pravica et al. revealed a novel SNP,[76] T to A, located at the +874 position from translation start site in the first intron of IFN-γ gene, which coincides with a putative nuclear transcription factor-kappa light-chain enhancer of activated B-cells (NF-κB)-binding site that could play a essential role in the induction of constitutively high IFN-γ production. The differences in the magnitudes of the responses that were seen may reveal the environment in which the cohorts live, or they may reflect the nature of the patients’ infections.[77] The disruption of the IFN-γ gene in mice infected with M. tuberculosis has resulted in the exacerbation of disease, progressive and extensive tissue destruction and necrosis with numerous bacteria.[78] Therefore, alteration in IFN-γ production may influence the susceptibility to FGTB, and this alteration could be due to gene polymorphism. The homozygous T/T, A/A and heterozygous A/T alleles are associated with increase or decrease in the production of IFN-γ, which can affect the outcome of the disease severity. Recently, the SNPs of TLR2 G to A substitution at position 2258 (2258G/A) [arginine to glutamine substitution at residue 753 (Arg753Gln)] and IFN-γ [T to A substitution at the +874 position located from the translation start site (+874T/A)] gene that leads to a decreased response of macrophages to microbial peptides associated with receptor hypo-responsiveness and attenuated immune response with the host have been reported.[66],[74],[76],[78],[79] TLR2 gene polymorphism results in an arginine (CGG) to a glutamine (CAG) substitution, and the resulting genotypes, therefore, are arginine/arginine (GG), glutamine/glutamine (AA) and arginine/glutamine (AG). The mechanisms through which these TLR2 polymorphisms affect host defence remain unclear. This apparent variability is probably accounted for by the involuntary selection of differential clinical presentations as a result of long-term host–pathogen interactions in certain regions or populations. However, the identification of factors involved in the aetiology and physiology of multifaceted disorders and conditions such as infertility is needed to understand potential regulatory mechanisms involved in disease pathogenesis. The determination of functional SNPs and biochemical phenotypes (e.g. the differential expression and function of innate immune molecules such as receptors, secondary mediators and cytokines by the host) in the immunopathogenesis of FGTB is necessary in assessing the contributions and functional consequences of specific genetic variations (polymorphisms) in the human genome with reverence to host susceptibility or resistance to TB.

Amplification refractory mutation system–multi-gene/multi-primer polymerase chain reaction

Mutation screening is one of the miscellaneous technologies useful to identify mutations or polymorphisms in candidate genes or genomic regions. Because the human genome sequence is available, polymerase chain reaction (PCR)-directed sequencing is adapted as one of the best methods for mutational analysis. Allele-specific PCR or amplification refractory mutation system (ARMS)–PCR is an ordinary technique used for the detection of point mutations or small deletions in several studies.[80] Unfortunately, assay design can be laborious if multiple genes or large regions need to be studied by simple PCR. Bhanothu et al. improved the ARMS–PCR to permit the rapid analysis of any known mutation in genomic DNA and established a system, ARMS–MG/MP PCR, which allows genotyping exclusively by the examination of reaction mixtures after agarose gel electrophoresis.[81] The principles and applications of MG/MP PCR and/or ARMS–multi-gene (MG)/multi-primer (MP) PCR in the clinical diagnosis of FGTB and mutational analysis are described elsewhere.[80],[81] The ARMS–MG/MP PCR consists of multiple primer sets within a single PCR mixture to produce products of varying sizes that are specific to diverse DNA sequences in a single tube reaction. MG/MP PCR method uses a single template along with several pairs of forward and reverse primers to amplify specific regions within a template. Amplification is also attainable with multiple templates or target sequences and several primer sets in the same reaction tube.

Potential problems in a simple PCR include false negatives due to reaction breakdown or false positives due to contamination. False negatives are often exposed in MG/MP PCR assays because each amplicon provides an internal control for the other amplified fragments. This problem can be overcome by designing or picking dedicated primers. The cost of reagents and preparation time can be less in MG PCR compared to other systems in which several tubes of uniplex PCRs are used. MG/MP PCR reactions decrease the cost by minimising the use of polymerase and templates. The quality of the template may be determined more effectively in a MG PCR than in a simple PCR reaction. This study aims to review the role of TLR2 and IFN-γ gene polymorphisms in M. tuberculosis infection leading to infertility and the role of TLR2-IFN-γ signalling immune defence mechanism. The review also brings out the importance of amplification refractory mutation system (ARMS)–MG/MP PCR and its role in the rapid detection of SNPs among latently infected individuals who are at risk of developing active TB and infertility.


  Materials and methods Top


Collection of literature and analysis

A systematic literature review was performed as part of a study aiming to know the gaps and available facts on the aetiological and pathological association of genetic polymorphisms in women with FGTB. The compilation of literature and revise of literature were conceded at the Department of Zoology, Osmania University, Hyderabad. This centre is connected with high-speed internet facilities permitted to access all international and national journals, e-journals and books. The exploration of facts was performed from September 03, 2006 to July 07, 2017 from all data sources including MEDLINE and the Cochrane Library (Wiley) from the date of inception, with no language limits. Several internet-associated search engines such as Pubmed-NCBI, Google and sources such as libraries were used for gathering associated data. Research articles were retrieved through search engines using specific terms such as ‘Female genital tuberculosis’, ‘Molecular and immunological factors of female genital tuberculosis’, ‘Use of genetic material in the detection of FGTB’ and ‘Etiological and pathological association of gene polymorphism with female genital tuberculosis’. Retrieved research articles, review articles, chapters from books, letters, editorials, commentaries, dissertation, books, erratum, notes, introductory, meeting abstracts, case reports, guidelines, conference proceedings, seminar presentations and abstracts were systematically studied. The related information from the articles were snowballed, corrected and presented. Quality evaluation was not an insertion criterion, because the aim was not to verify the gene polymorphism in the given population but to know the gaps, facts and its relationship with infertility and mycobacterium infection. Sample population included in the study was from reproductive age stratum. Excluded manuscripts were those describing studies without the information of gene polymorphism, FGTB and infertility. Enormous information got out of exploration were collectively filtered and selectively stored, and the rest of the unwanted literature was excluded.


  Results Top


Data from published manuscripts relating to randomised controlled trials, pilot and expediency studies of genetic association with tuberculosis susceptibility were gathered. Data were extracted from eligible manuscripts pertaining to the pathological and aetiological association of genetic polymorphisms in women with FGTB. Using Google search engine (https://www.google.co.in/#hl=enandoutput=searchandsclient) for about 1,02,000 citations, the title ‘Patho-etiological association of gene polymorphism with female genital tuberculosis’ was noted. Using PubMed-NCBI search engine (http://www.ncbi.nlm.nih.gov/pubmed), about 163 articles were identified, out of which, four were connected to the topic of investigation.

About 1310 citations were noted by title ‘Use of genetic material in the detection of FGTB’. Using PubMed-NCBI search engine (http://www.ncbi.nlm.nih.gov/pubmed), about four articles were documented, out of which, three were associated to the topic of investigation. The details of search engine outcomes are specified in [Table 3]. The outcome of the survey showed very little information about ‘Patho-etiological association of gene polymorphism with female genital tuberculosis’ and ‘Use of genetic material in the detection of FGTB’. However, unrelated information was also seen during the search and was discarded. Therefore, this indicates that there is a need to provide quality information on the mutational association of FGTB in an approach to enhance the research in this area. This review article attempted to summarise the use of technological developments in the detection of gene polymorphism and FGTB disease among infertile patients.
Table 3: The collection of literature on the aetiological association of gene polymorphism with female genital tuberculosis (FGTB)

Click here to view



  Discussion Top


FGTB usually occurs in women <40 years of age[82] and may simulate ovulation dysfunction that often presents with absent, excessive or non-cyclical menstruation.[83] Even foetal growth retardation was noted in several studies due to TB.[84],[85] It is a major cause of sub-fertility and infertility and is rarely diagnosed.[5],[86] The aetiology of infertility is an important criterion for the identification and categorisation of GTB in infertile women.[87],[88] Similarly, Bhanothu et al. reported a strong relationship between FGTB and infertility among women with diverse clinical presentations.[89] The significance of FGTB among all forms of TB has not yet been determined in developing countries. Such a situation is due to the complexity in clinical diagnosis, which is possible by laparoscopic investigations or endometrial biopsy or the culturing of M. tuberculosis or hispathologic analysis or MG/MP PCR,[89],[90],[91] but are not always available. Such as circumstance is also expected due to the lack of reliable data and strategy for early diagnosis. All organs are exaggerated by EPTB; however, the recurrence of the diverse clinical spots varies with region to region.[89],[92] The reason why some organs are affected aetiologically and pathologically more than others in these scenarios is not well understood. However, as detected in the pre-antibiotic era, the EPTB often has a favourable outcome[89],[93] when compared to PTB.[94] Therefore, the early detection of the disease and the identification of factors associated with FGTB susceptibility are of current importance.

Intricate interactions between host and pathogen have been described to affect the outcome of disease, including clinical severity, susceptibility and the latent forms of infections, and subsequently the development of infertility. Once the immunity to M. tuberculosis contains and overrules the growth of a small number of disseminated TB bacilli after primary infection, the infection may remain silent throughout the life until overwhelming re-infection precipitates the disease due to lowered immunity.[95] Patients in whom the infection converts into disease, cavitary lesions are developed and the bacteria increase in number in the caseous detritus. Patients with such a type of lesion are highly infectious,[96] and the classic symptoms of GTB such as persistent inflammation associated with bloody vaginal discharge, postmenopausal bleeding, pelvic pain, menorrhagia, oligomenorrhea, dysmenorrhoea, beaded tubes, tubal blocks, hydrosalpinges, tubo-ovarian mass and failure of implantation are noted. Menstrual disturbances are more likely when the female genital tract (FGT) is involved in tubercular process. The infections depend on the site of inflammation,[91] and the spread of pathogen to the reproductive organs leads to a variety of clinical conditions[11] including infertility. In fact, fertility is also profoundly affected, not only by systemic infections that directly or indirectly target the reproductive organs, but also by various illnesses including intrauterine growth restriction, pre-eclampsia, preterm birth, recurrent pregnancy loss, endometritis, endometriosis[97],[98] polycystic ovaries syndrome, ovarian cancer, chronic inflammatory conditions initiated due to genetic polymorphisms or genetic alterations and abnormalities in various genes and chromosomes.[66],[69],[73],[81],[99],[100] A number of studies on susceptible genes and genome-wide linkage scans[101] have identified the association of several functional SNPs to TB susceptibility.[16] Despite the significant role that TLR2 and IFN-γ plays in immune defence and human reproduction, little is known about the polymorphism of these genes[64],[73] in infertile women with FGTB.[81] A mutation in TLR2 specifically inhibited M. tuberculosis-induced cytokine production, and this inhibition was incomplete and thereby suggested that beside TLR2 polymorphism other genes may be involved.[37] Yet, there is no direct evidence that this polymorphism causes a decline in immune response specifically to M. tuberculosis. Polymorphism in genes encoding cytokines such as IFN-γ, tumour necrosis factor-α (TNF-α) along with other immune mediators has been associated with increased susceptibility to TB in different populations. This may also play a role in the pathophysiology of the disease.[67],[74] Gene mutations in the TLR2 pathway are also reported in persons with M. tuberculosis[67],[102] infections. Darville et al. reported genital tract infection by C. trachomatis in transgenic mice lacking TLR2.[103] In the TLR2 knockout mice, significantly lower levels of the inflammatory cytokines, TNF-α and macrophage inflammatory protein-2 have been reported in the genital tract secretions. Despite the variation in cytokine production, the course of infection, however, remained the same in all animals with sufficient effectors cells recruited to the genital tract to clear the infection. The reduced pathology in TLR2 knockout mice is of particular interest; however, the animals showed decreased inflammatory cell infiltration, dilatation and hydrosalpinx within the fallopian tubes. The TLR2 2258A is reported to have a significant decrease in NF-κB response against bacterial peptides in human embryonic kidney (HEK)-293 T-cells transfected with wild type or TLR2 2258G/A constructs.[66],[104] The progression of the disease in chronic oviductal pathology mediated by TLR2 gene polymorphism is also reported.

Despite these, Bhanothu et al. used MG/MP PCR to determine whether certain organs had an affinity for M. tuberculosis.[89],[93] Bhanothu et al. also explained the relevance of TLR2 and IFN-γ genes in the context of varied clinical presentations with the site-specific pathology of TB infection[81] and partly described the tissue-specific expression of gene polymorphisms and genetic abnormality leading to atypical gene regulation[105],[106] in infertile women with FGTB. The genotype distribution of TLR2 gene is not differing significantly between the patients with FGTB and healthy controls. There is no evidence of an association between the TLR2 gene polymorphisms and its role in inducing infertility among patients infected with M. tuberculosis and control patients without TB.[81] Bhanothu et al. suggested that TLR2 gene polymorphism may not be the influencing factor in the disease susceptibility, but defects in the factors other than TLR2 are suspected in infertility and in inducing latent TB among such infertile patients.[81] Bhanothu et al. could probably suggest a limited role of the TLR2 gene and its polymorphisms in disease susceptibility.[81] However, TLR2 (R753Q) polymorphism has been described in association with susceptibility to several infectious diseases. Many functional and genetic studies confirmed that SNPs in TLRs have the ability to both modify receptor function and increase the susceptibility of the host to TB infection. So far, no functional domains have been identified in human TLR2, but the potential functions of the carboxy terminus include dimerisation to form TLR2 homodimers or heterodimers with downstream targets such as adaptor molecules namely MyD88, TIRAP/MAL, TRIF/TICAM1, TRAM and SARM. Infections in animal models suggest that the haematogenous spread of infection occurred before the onset of T-cell-mediated immunity.[107] This supports the hypothesis that the ability of the different strains of M. tuberculosis to produce different clinical phenotypes depends upon their interaction with the host innate and adaptive immune responses, but the relevance of these findings to human disease still remains uncertain.[108] However, it is possible that more common genetic variants such as promoter region polymorphisms that influence gene expression may be associated with certain diseases. The heterogeneity in the clinical expression of FGTB strongly suggests the role of genetic and environmental factors in immune pathogenesis along with aetiology. This also affects the differential expression of genes such as TLRs, cytokines, chemokines and lymphokines found in the host immune response and human reproductive system.[109] The manifestations of clinical presentations such as beaded tubes, tubal block with hydrosalphinx, tubercular salphingitis and omental adhesions along with menstrual complications are correlated due to genetic variations in the bacterial strain and the extraordinary virulent nature of mycobacterium including the genetic makeup and genetic mutation of the host.

Infertile women with M. tuberculosis infection have the standard levels of TLR2 expression, which may be sufficient to induce a local Th1-type host defence (i.e. IFN-γ production) against the infections. However, fluctuation in the production of IFN-γ and its role in pathogenesis have been described to be due to specific mutation in IFN-γ +874A/T gene.[76],[110],[111] IFN-γ+874(T/A) polymorphism lies within the transcription factor-binding site of the NF-κB and is responsible for the unusual binding pattern of specific alleles. The mechanism by which the IFN-γ +874T/A allele influences the susceptibility to FGTB may depend on its role in the regulation of IFN-γ production. The T allele of IFN-γ +874T/A presents a binding site for the NF-κB, which is able to regulate IFN-γ expression.[76] Heterozygous carriers have a transitional phenotype, more subtle variation in the IFN-γ response pathway and may underlie the susceptibility to TB in human populations.[112] Mice deficient in the IFN-γ gene expression are very susceptible to fatal TB.[110],[113] The higher levels of IFN-γ production along with other cytokines suggest the role of cytokines in infertility, diagnosis and treatment.[114] Mutations that modulate the IFN-γ production have been coupled with different clinical presentations,[115],[116] outcome of active TB and in the aetiology of female infertility due to mycobacterial infections.[117],[118] The endogenous ligands identified in other systems have suggested the significant role of TLRs in the normal functioning of the ovary and endometrium through the menstrual cycle. The remarkable levels of IFN-γ may be due to genetic variations that lead to the susceptibility of TB infections and infertility. M. tuberculosis-induced IFN-γ seems to be the downstream effectors molecule of TLR2 activation results in the mitigation of TB induced infertility among women. Bhanothu et al. suggest that a deficient IFN-γ signalling in infertile women could lead to the loss of bacterial infection-mediated protection of the genital organs.[81] M. tuberculosis-induced IFN-γ production depends on TLR2 signalling and thus exerts regulatory effects on fertility in women with FGTB. TLR2-IFN-γ signalling pathway may also yield novel insights into the regulatory mechanisms of immune cells in infertile women associated with genital infections such as FGTB. Bhanothu et al. reported that the distribution of IFN-γ gene polymorphism is consistent with earlier information; however, the distribution of TLR2 gene polymorphism is different from the earlier findings.[73] Bhanothu et al. noted a significant correlation of the disease with IFN-γ gene polymorphism but not with TLR2 gene polymorphism.[81],[111] Bhanothu et al. also had shown the role of TLR2 gene polymorphism in association with disease resistance in humans. Therefore, the genetic variants of TLR2 and IFN-γ can be utilised as biomarkers in the early detection of women with FGTB.

Disparity in the statistical distribution of polymorphism may be due to an extended duration of infertility, polluted environment and the nutritional status of individual. Limited information is available on gene polymorphism in association with infertility, and this may perhaps confine our understanding about disease and statistical disparity in the genotype. Validations of the findings among independent co­horts are needed to firmly establish the role of TLR2 gene polymorphism in conditions such as organ dysfunctions and infertility with varying clinical presentations. A final proof of their functional relevance requires further studies that could determine their realistic effects on immune response. This review concluded that the study by a larger cohort of infertile patients with FGTB is warranted to identity the risk factors and candidates or susceptible genes. This review also supports the perception that genetics, immunology, environment and different strains of infecting agents may play a vital role in the aetiology and pathogenesis of FGTB among infertile patients. The review provides conceptual advances useful in the understanding of the onset and progress of TB. Further, this review also suggests that the identification of the asymptomatic nature of the disease, the accessibility of reproductive clinics, the elucidation of genes associated with virulence and susceptible factors, the detection of interspecies and intraspecies differences among genome sequences and gene expression are importance attempts to understand the aetiology and pathogenesis of FGTB disease.

TLR2 receptor is extremely implicated in the field of adjuvant, pathogen and probiotic agents at the point of entry. IFN-γ is involved in carrying the TLR2 signalling cascades and immune modulation in the event of pathogen elimination. The determination of functional SNPs and biochemical phenotypes (e.g. the differential expression and functions of innate immune molecules such as receptors, secondary mediators and cytokines by the host) in the immunopathogenesis of FGTB is required. It is then possible to differentiate the early and late stages of the disease by identifying stage-specific biomarkers that could differentiate between each stage. It is, therefore, necessary to screen a variety of candidate genes, such as those for cytokines and the members of the TLR2-IFN-γ-mediated signalling pathway with positive IFN-γ/IL-12 feedback loop. This also supports the hypothesis that the functional polymorphism in the gene-encoding TLR2 function may not be a rate-limiting component for containment by the human innate immune system and natural gram-positive bacterial infections (due to extra- and/or intracellular pathogens) along with the role of other factors. Therefore, more research is needed to correlate mutations in TLR2 and IFN-γ with functional consequences.

An improved understanding of innate and adaptive immunity within the FRT may help to develop interceptive strategies against the pathogens and clinical outcomes. By understanding the physiology and molecular mechanisms that govern M. tuberculosis infection and host cell interactions with specific bacterial molecules at different stages of infections can be targeted for rational of FGTB diagnosis and strategies to control TB infections. Advanced nucleic acid-based methods such as MG/MP PCR can be utilised not only for bacteriological presence but also in the clinical findings of host in response to infectious agents. This technique on slight modification can be used in the detection of SNPs, mutations, gene deletions and in the comparative analysis of various biomarkers. However, sex disparity in TB notification rates have been stated frequently, with a higher incidence in males. This discrepancy is commonly explained by either under-diagnosis or under-reporting of TB in females. A study of the sex ratio among patients with TB in San Francisco,[119] on the basis of clustering statistics, recommended that the sex divergence may be due to a difference in transmission dynamics rather than under-diagnosis. The variation in transmissibility and virulence among M. tuberculosis strains has been related to the genetic background, diverse lineages with specific geographical regions and the ethnicity of the host population.[120],[121] It may be due to an inconsistency in infection and/or the progression of disease.[122] A broad range of gender disparity was noticed among the patients with GTB infections, with 78.5% of the patients being females.[93] However, the rate was comparatively low (42.8%) in female patients with PTB <21 years old and increased significantly in patients more than 21 years old and reached 89% in patients between 31 and 40 years old.[123] The global rate of clustering in female patients was higher than that in male patients. A high rate of clustering is associated with recent infection and rapid progression to disease.[124] There may be numerous explanations for the higher rate of clustering in middle-aged women. It is likely that women are more disturbed by immunodeficiency, and women may progress more rapidly to diseases.[122],[125] Because women’s health has an impact on both their families and the economy, the inclusion of sex difference in TB control programs could yield more beneficial outcomes.[126] It is more likely that socio-economic and cultural factors (poverty and the crowded state of life, individual’s age, environment, lifestyle, nutritional status, close pregnancies, prolonged breast-feeding and so forth) affect the rates of TB infection. Therefore, understanding the multifaceted role of one’s genotype, environment and age with changes in one’s epigenotype could further sort the unknown causes of the disease. The correlation of epidemiological examinations along with the aforementioned factors could provide a greater understanding of different gene regulatory pathways and their effect[127] on human diseases.

Acknowledgement

We are grateful to National Post Doctoral Fellowship scheme, SERB-DST, Govt of India for providing research fellowship and grants in sciences for meritorious scientists.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Romero RR, Romero GG, Abortes MI, Medina SH. Risk factors associated to female infertility. Ginecol Obstet Mex 2008;76:717-21.  Back to cited text no. 1
    
2.
Namavar JB, Parsanezhad ME, Ghane-Shirazi R. Female genital tuberculosis and infertility. Int J Gynaecol Obstet 2001;75:269-72.  Back to cited text no. 2
    
3.
Tripathy SN, Tripathy SN. Infertility and pregnancy outcome in female genital tuberculosis. Int J Gynaecol Obstet 2002;76:159-63.  Back to cited text no. 3
    
4.
Gupta N, Sharma JB, Mittal S, Singh N, Mishra R, Kukreja M. Genital tuberculosis in Indian infertility patients. Int J Gynaecol Obstet 2007;97:135-8.  Back to cited text no. 4
    
5.
Dam P, Shirazee HH, Goswami SK, Ghosh S, Ganesh A, Chaudhury K et al. Role of latent genital tuberculosis in repeated IVF failure in the Indian Clinical setting. Gynecol Obstet Invest 2006;61:223-7.  Back to cited text no. 5
    
6.
Parikh FR, Naik N, Nadkarni SG, Soonawala SB, Kamat SA, Parikh RM. Genital tuberculosis: A major pelvic factor causing infertility in Indian women. Fertil Steril 1997;67:497-500.  Back to cited text no. 6
    
7.
Saraswat P, Swarankar ML, Bhandari A, Soni RR. Detection of active female genital tuberculosis by molecular method. Int J Pharm Bio Sci 2010;1:B328-34.  Back to cited text no. 7
    
8.
Chakrabarti AK, Sen S, Banerjee A, Roy K. Female genital tuberculosis − A retrospective study. Indian J Tuberc 1998;45:101-3.  Back to cited text no. 8
    
9.
Gatongi DK, Gitau G, Kay V, Ngwenya S, Lafong C, Hasan A. Female genital tuberculosis. Obstet Gynaecol 2005;7:75-9.  Back to cited text no. 9
    
10.
Angus BJ, Yates M, Conlon C, Byren I. Cutaneous tuberculosis of the penis and sexual transmission of tuberculosis confirmed by molecular typing. Clin Infect Dis 2001;33:132-4.  Back to cited text no. 10
    
11.
Simon HB, Weinstein AJ, Pasternak MS, Swartz MN, Kunz LJ. Genitourinary tuberculosis: Clinical features in a general hospital population. Am J Med 1977;63:410-20.  Back to cited text no. 11
    
12.
Heinonen PK, Teisala K, Punnonen R, Miettinen A, Lehtinen M, Paavonen J. Anatomic sites of upper genital tract infection. Obstet Gynecol 1985;66:384-90.  Back to cited text no. 12
    
13.
Kurman RJ, editor. Genital Tract. Blaustein’s Pathology of the Female. 5th ed. New York: Springer-India; 2002. p. 230.  Back to cited text no. 13
    
14.
Miller JW, Holt S, Gilmour HM, Robertson DH. Vulval tuberculosis. Tubercle 1979;60:173-6.  Back to cited text no. 14
    
15.
Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc Nephrol 2001;121:307-14.  Back to cited text no. 15
    
16.
Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun 2012;80:3343-59.  Back to cited text no. 16
    
17.
Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull 2005;28:886-92.  Back to cited text no. 17
    
18.
Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med 2014;32:35-42.  Back to cited text no. 18
    
19.
Hedges SR, Agace WW, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995;3:266-70.  Back to cited text no. 19
    
20.
Nasu K, Narahara H. Pattern recognition via the toll-like receptor system in the human female genital tract. Mediat Inflamm 2010;2010:976024.  Back to cited text no. 20
    
21.
Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.  Back to cited text no. 21
    
22.
Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: Cellular responses and interactions. Immunol Rev 2005;206:306-35.  Back to cited text no. 22
    
23.
Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003;85:85-95.  Back to cited text no. 23
    
24.
Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-80.  Back to cited text no. 24
    
25.
West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006;22:409-37.  Back to cited text no. 25
    
26.
Medzhitov R, Janeway CA Jr. Decoding the patterns of self and non-self by the innate immune system. Science 2002;296:298-300.  Back to cited text no. 26
    
27.
Akira S. Mammalian toll-like receptors. Curr Opin Immunol 2003;15:5-11.  Back to cited text no. 27
    
28.
Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD et al. The evolution of vertebrate toll-like receptors. Proc Natl Acad Sci USA 2005;102:9577-82.  Back to cited text no. 28
    
29.
Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR. Toll like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004;112:428-36.  Back to cited text no. 29
    
30.
Fazeli A, Bruce C, Anumba DO. Characterization of toll-like receptors in the female reproductive tract in humans. Hum Reprod 2005;20:1372-8.  Back to cited text no. 30
    
31.
Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M et al. Evidence for the presence of toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005;90:548-56.  Back to cited text no. 31
    
32.
Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, Guyre PM. Differential expression of toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004;72:5799-806.  Back to cited text no. 32
    
33.
Strömbeck L. Vaginal commensal bacteria: Interactions with cervix epithelial and monocytic cells and influence on cytokines and secretory leukocyte protease inhibitor (SLPI). Thesis printed by Intellecta Infolog. Gothenburg, Sweden: The Sahlgrenska Academy; 2008. [ISBN 978-91-628-7659-3].  Back to cited text no. 33
    
34.
Aflatoonian R, Tuckerman E, Elliott SL, Bruce C, Aflatoonian A, Li TC et al. Menstrual cycle-dependent changes of toll-like receptors in endometrium. Hum Reprod 2007;22:586-93.  Back to cited text no. 34
    
35.
Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 1997; 272:L989–95.  Back to cited text no. 35
    
36.
Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan and lipoteichoic acid-induced cell activation is mediated by toll like receptor 2. J Biol Chem 1999;274:17406-9.  Back to cited text no. 36
    
37.
Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999;96:14459-63.  Back to cited text no. 37
    
38.
Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-71.  Back to cited text no. 38
    
39.
Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z et al. Cutting edge role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169:10-4.  Back to cited text no. 39
    
40.
Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732–6.  Back to cited text no. 40
    
41.
Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 2006;177:422-9.  Back to cited text no. 41
    
42.
Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immunol 2004;173:2660–8.  Back to cited text no. 42
    
43.
Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001;291:1544-7.  Back to cited text no. 43
    
44.
Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: A role for toll-like receptors. Nat Rev Microbiol 2010;8:296-307.  Back to cited text no. 44
    
45.
Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guérardel Y, Nigou J et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004;172:4425-34.  Back to cited text no. 45
    
46.
Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT et al. Different toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001;69:1036-44.  Back to cited text no. 46
    
47.
Wallin RP, Lundqvist A, Moré SH, von Bonin A, Kiessling R, Ljunggren HG. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002;23:130-5.  Back to cited text no. 47
    
48.
Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. TLR-2 promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunol Biol 2008;213:205-24.  Back to cited text no. 48
    
49.
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.  Back to cited text no. 49
    
50.
Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila toll. Proc Natl Acad Sci USA 1998;95:588-93.  Back to cited text no. 50
    
51.
Beutler B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004;430:257-63.  Back to cited text no. 51
    
52.
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-95.  Back to cited text no. 52
    
53.
Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2–>MyD88–>IRAK–>TRAF–>NIK–>IKK–>NF-kappa B signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001;69:2270-6.  Back to cited text no. 53
    
54.
Van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309.  Back to cited text no. 54
    
55.
Flynn JL, Chan J, Lin PL. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol 2011;4:271-8.  Back to cited text no. 55
    
56.
Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012;7:353-84.  Back to cited text no. 56
    
57.
Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol 2012;3:1-17.  Back to cited text no. 57
    
58.
Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, Pickrell JK et al. Evolutionary dynamics of human toll-like receptors and their different contributions to host defense. PLoS Genet 2009;5:e1000562.  Back to cited text no. 58
    
59.
Trowsdale J. The MHC, disease and selection. Immunol Lett 2011;137:1-8.  Back to cited text no. 59
    
60.
Bekpen C, Xavier RJ, Eichler EE. Human IRGM gene “to be or not to be”. Semin Immunopathol 2010;32:437-44.  Back to cited text no. 60
    
61.
Eriksson M, Meadows SK, Basu S, Mselle TF, Wira CR, Sentman CL. TLRs mediate IFN-(gamma) production by human uterine NK cells in endometrium. J Immunol 2006;176:6219-24.  Back to cited text no. 61
    
62.
Fricke I, Mitchell D, Mittelstädt J, Lehan N, Heine H, Goldmann T et al. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J Immunol 2006;176:5173-82.  Back to cited text no. 62
    
63.
Shimada M, Yanai Y, Okazaki T, Noma N, Kawashima I, Mori T et al. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 2008;135:2001-11.  Back to cited text no. 63
    
64.
Girling JE, Hedger MP. Toll-like receptors in the gonads and reproductive tract: Emerging roles in reproductive physiology and pathology. Immunol Cell Biol 2007;85:481-9.  Back to cited text no. 64
    
65.
Holland SM, Casanova JL. Inherited disorders of the interleukin-12-interleukin-23/interferon-gamma circuit. In: Hans DO, Smith CI, Puck JM, editors. Primary Immunodeficiency Diseases: A Molecular and Cellular Approach. USA: OUP; 2013. p. 450-65. [Chapter 35].  Back to cited text no. 65
    
66.
Ogus C, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I et al. The Arg753Gln polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004;23:219-23.  Back to cited text no. 66
    
67.
Velez DR, Wejse C, Stryjewski ME, Abbate E, Hulme WF, Myers JL et al. Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet 2010;127:65-73.  Back to cited text no. 67
    
68.
Yim JJ, Ding L, Schäffer AA, Park GY, Shim YS, Holland SM. A microsatellite polymorphism in intron 2 of human toll-like receptor 2 gene: Functional implications and racial differences. FEMS Immunol Med Microbiol 2004;40:163-9.  Back to cited text no. 68
    
69.
Woehrle T, Du W, Goetz A, Hsu HY, Joos TO, Weiss M et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008;41:322-9.  Back to cited text no. 69
    
70.
Yim JJ, Adams AA, Kim JH, Holland SM. Evolution of an intronic microsatellite polymorphism in toll-like receptor 2 among primates. Immunogenetics 2006;58:740-5.  Back to cited text no. 70
    
71.
Gautam JK, Ashish , Comeau LD, Krueger JK, Smith MF Jr. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J Biol Chem 2006;281:30132-42.  Back to cited text no. 71
    
72.
Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P et al. Toll-like receptor-1, −2 and −6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006;12:1-8.  Back to cited text no. 72
    
73.
Dalgic N, Tekin D, Kayaalti Z, Soylemezoglu T, Cakir E, Kilic B et al. Arg753Gln polymorphism of the human toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum Immunol 2011;72:440-5.  Back to cited text no. 73
    
74.
Pacheco AG, Cardoso CC, Moraes MO. IFNG +874T/A, IL10 21082G/A and TNF 2308G/A polymorphisms in association with tuberculosis susceptibility: A meta-analysis study. Hum Genet 2008;123:477-84.  Back to cited text no. 74
    
75.
Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat 2009;30:1237-44.  Back to cited text no. 75
    
76.
Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of human interferon-γ gene: Absolute correlation with a polymorphic C/A microsatellite marker of high interferon-γ production. Hum Immunol 2000;61:863-6.  Back to cited text no. 76
    
77.
Cahn P, Perez H, Ben G, Ochoa C. Tuberculosis and HIV: A partnership against the most vulnerable. J Int Assoc Physicians AIDS Care (Chic) 2003;2:106-23.  Back to cited text no. 77
    
78.
Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-42.  Back to cited text no. 78
    
79.
Reiling N, Hölscher C, Fehrenbach A, Kröger S, Kirschning CJ, Goyert S et al. Cutting edge: Toll-like receptor (TLR) 2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002;169:3480-4.  Back to cited text no. 79
    
80.
Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.  Back to cited text no. 80
    
81.
Bhanothu V, Lakshmi V, Theophilus JP, Rozati R, Badhini P, Vijayalaxmi B. Investigation of toll-Like receptor-2 (2258G/A) and interferon gamma (+874T/A) gene polymorphisms among infertile women with female genital tuberculosis. PLoS One 2015;10:e0130273.  Back to cited text no. 81
    
82.
Chaudhary NN. Overview of tuberculosis of the female genital tract. J Indian Med Assoc 1996;94:345-61.  Back to cited text no. 82
    
83.
Lantheaume S, Soler S, Issartel B, Isch JF, Lacassin F, Rougier Y et al. Peritoneal tuberculosis simulating advanced ovarian carcinoma: A case report. Gynecol Obstet Fertil 2003;31:624-6.  Back to cited text no. 83
    
84.
Figneroa-Ddomain R, Arredondo-Garcia JL. Neonatal outcome of children born to women with tuberculosis. Med Res 2001;2:66-99.  Back to cited text no. 84
    
85.
Kothari A, Mahadewan N, Girling J. Tuberculosis in pregnancy − Result of a study in high prevalence area in London. Eur J Obstet Gynecol Reprod Biol 2006;126:48-55.  Back to cited text no. 85
    
86.
Sharma JB, Roy KK, Pushpraj M, Kumar S, Malhotra N, Mittal S. Laparoscopic findings in female genital tuberculosis. Arch Gynecol Obstet 2008;278:359-64.  Back to cited text no. 86
    
87.
Busso D, Onate-Alvarado MJ, Balboa E, Zanlungo S, Moreno RD. Female infertility due to anovulation and defective steroidogenesis in NPC2 deficient mice. Mol Cell Endocrinol 2010;315:299-307.  Back to cited text no. 87
    
88.
Cai X, Song R, Long M, Wang SF, Ma YR, Li X et al. A cross-sectional study on the current status of female infertility in three counties of Xinjiang Uygur Autonomous Region. Zhonghua Yi Xue Za Zhi 2011;91:3182-5.  Back to cited text no. 88
    
89.
Bhanothu V, Theophilus JP, Rozati R. Use of endo-ovarian tissue biopsy and pelvic aspirated fluid for the diagnosis of female genital tuberculosis by conventional versus molecular methods. PLoS One 2014;9:e98005. doi: 10.1371/journal.pone.0098005.  Back to cited text no. 89
    
90.
Güngördük K, Ulker V, Sahbaz A, Ark C, Tekırdag AI. Postmenopausal tuberculosis endometritis. Infect Dis Obstet Gynecol 2007;207:27028-30.  Back to cited text no. 90
    
91.
Mares M, Socolov D, Doroftei B, Botezatu A, Goia CD. The prevalence of some bacterial markers in female patients undergoing an initial infertility evaluation in north-east Romania. Roum Arch Microbiol Immunol 2009;68:171-4.  Back to cited text no. 91
    
92.
Aurégan G. Originalités de la tuberculose dans les pays en voie de développement. Ann Inst Pasteur 1993;4:208-15.  Back to cited text no. 92
    
93.
Bhanothu V, Theophilus JP, Reddy PK, Rozati R. Occurrence of female genital tuberculosis among infertile women: A study from a tertiary maternal health care research centre in South India. Eur J Clin Microbiol Infect Dis 2014;33:1-12.  Back to cited text no. 93
    
94.
Hopewell PC. Overview of clinical tuberculosis. In: Bloom BB, editor. Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: American Society for Microbiology; 1994. p. 25-46.  Back to cited text no. 94
    
95.
Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: Renewal of old acquaintances. Clin Infect Dis 2007;45:436-8.  Back to cited text no. 95
    
96.
Doherty TM, Andersen P. Vaccines for tuberculosis: Novel concepts and recent progress. Clin Microbiol Rev 2005;18:687-702.  Back to cited text no. 96
    
97.
Bhanothu V, Rozati R, Theophilus J. Prevalence and polymorphism in interferon-γ gene (CA) repeats with different stages of endometriosis. Am J Med Biol Res 2013;1:1-5.  Back to cited text no. 97
    
98.
Bhanothu V, Theophilus J, Lakshmi V, Rozati R, Aiman AV, Rosaline M et al. Detection of female genital tuberculosis by using endo-ovarian tissue biopsy. Octa J Biosci 2013;1:98-107.  Back to cited text no. 98
    
99.
Swiderek WP, Bhide MR, Gruszczyńska J, Soltis K, Witkowska D, Mikula I. Toll-like receptor gene polymorphism and its relationship with somatic cell concentration and natural bacterial infections of the mammary gland in sheep. Folia Microbiol 2006;51:647-52.  Back to cited text no. 99
    
100.
Wang X, Xu S, Gao X, Ren H, Chen J. Genetic polymorphism of TLR4 gene and correlation with mastitis in cattle. J Genet Genomics 2007;34:406-12.  Back to cited text no. 100
    
101.
Mahasirimongkol S, Yanai H, Mushiroda T, Promphittayarat W, Wattanapokayakit S, Phromjai J et al. Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. J Hum Genet 2012;57:363-7.  Back to cited text no. 101
    
102.
Vannberg FO, Chapman SJ, Hill AV. Human genetic susceptibility to intracellular pathogens. Immunol Rev 2011;240:105-16.  Back to cited text no. 102
    
103.
Darville T, O’Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003;171:6187-97.  Back to cited text no. 103
    
104.
Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-401.  Back to cited text no. 104
    
105.
Samuels DC, Li C, Li B, Song Z, Torstenson E, Boyd Clay H et al. Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genet 2013;9:e1003929.  Back to cited text no. 105
    
106.
Satgé D. Analysis of somatic mutations in cancer tissues challenges the somatic mutation theory of cancer. eLS 2013. doi: 10.1002/9780470015902.a0024465.  Back to cited text no. 106
    
107.
Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002;70:4501-9.  Back to cited text no. 107
    
108.
Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ et al. Hypervirulent M. tuberculosis W/Beijing strains up regulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J Interferon Cytokine Res 2005;25:694-701.  Back to cited text no. 108
    
109.
Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V et al. Association of transforming growth factor-β1 and tumor necrosis factor alpha polymorphisms with anti-SSB/Lα antibody secretion in patients with primary Sjogren’s syndrome. Arthritis Rheum 2004;50:570-80.  Back to cited text no. 109
    
110.
Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J Exp Med 1993;178:2243-8.  Back to cited text no. 110
    
111.
Bhanothu V, Theophilus J, Rozati R. Mutational analysis of interferon-gamma gene in Indian women with female genital tuberculosis. Int J Curr Res Rev 2012;4:130-40.  Back to cited text no. 111
    
112.
Levin M, Newport MJ, D’Souza S, Kalabalikis P, Brown IN, Lenicker HM et al. Familial disseminated atypical mycobacterial infection in early childhood: A human mycobacterial susceptibility gene? Lancet 1995;345:79-83.  Back to cited text no. 112
    
113.
Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.  Back to cited text no. 113
    
114.
Naz RK, Butler A, Witt BR, Barad D, Menge AC. Levels of interferon-gamma and tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: Implication in infertility. J Reprod Immunol 1995;29:105-17.  Back to cited text no. 114
    
115.
Cotter Todd W, Ramsey Kyle H, Miranpuri Gurwattan S, Poulsen Christoffer E, Byrne Gerald I. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 1997;65:2145-52.  Back to cited text no. 115
    
116.
Roth A, König P, van Zandbergen G, Klinger M, Hellwig-Bürgel T, Däubener W et al. Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo. PNAS 2010;107:19502-7.  Back to cited text no. 116
    
117.
Bansal C, Lal N, Goyal A, Srivastava AN. Genital tuberculosis and endometriosis coexisting in an infertile female. Indian J Med Spec 2012;3:91-3.  Back to cited text no. 117
    
118.
Lopes MQ, de Figueiredo Texeixeira RL, de Miranda AB, Pinto RS, Lizânia B, Mello FC et al. Influence of the interferon-gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) gene polymorphisms in TB occurrence and clinical spectrum. In: Mahboub BH, Vats MG, editors. Tuberculosis − Current Issues in Diagnosis and Management. In Tech; 2013. p. 79-104.  Back to cited text no. 118
    
119.
Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. Int J Tuberc Lung Dis 2000;4:26-31.  Back to cited text no. 119
    
120.
Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007;7:328-37.  Back to cited text no. 120
    
121.
Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN. Comparison of pulmonary and extrapulmonary tuberculosis in Nepal − A hospital-based retrospective study. BMC Infect Dis 2008;8:1-7. doi: 10.1186/1471-2334- 8-8.  Back to cited text no. 121
    
122.
Holmes CB, Haulser H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis 1998;2:96-104.  Back to cited text no. 122
    
123.
Rasolofo RV, Ménard D, Aurégan G, Gicquel B, Chanteau S. Extrapulmonary and pulmonary tuberculosis in antananarivo (Madagascar): High clustering rate in female patients. J Clin Microbiol 2002;40:3964-9.  Back to cited text no. 123
    
124.
Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.  Back to cited text no. 124
    
125.
Hudelson P. Gender differentials in tuberculosis: The role of socioeconomic and cultural factors. Tuberc Lung Dis 1996;77:391-400.  Back to cited text no. 125
    
126.
Uplekar MW, Rangan S, Weiss MG, Ogden J, Borgdorff MW, Hudelson P. Attention to gender issues in tuberculosis control. Int J Tuberc Lung Dis 2001;5:220-4.  Back to cited text no. 126
    
127.
Bjornsson HT, Daniele Fallin M, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet 2004;20:350-8.  Back to cited text no. 127
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Materials and me...
Results
Discussion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed85    
    Printed0    
    Emailed0    
    PDF Downloaded5    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]